4-[(1H-imidazol-4-yl) methyl] benzamidines and benzylamidines: novel antagonists of the histamine H3 receptor

Bioorg Med Chem Lett. 1998 Aug 18;8(16):2263-8. doi: 10.1016/s0960-894x(98)00399-0.

Abstract

A series of amidine substituted phenyl-, benzyl-, and phenethylimidazoles based on the known H3 agonist SK&F 91606 (4) has been synthesized and tested as ligands for the histamine H3 receptor. Insertion of a phenyl ring between the imidazole ring and the amidine moiety produces antagonists. The benzyl series was found to be the most potent and was further investigated. Compounds 9c and 18 (entries 5 and 12, Table 1) are potent ligands for the H3 receptor with K(i) values of 16 nM and 7.2 nM respectively. In vivo, both compounds were shown to be equipotent to thioperamide (2), the standard H3 antagonist.

MeSH terms

  • Animals
  • Benzamidines / chemical synthesis*
  • Benzamidines / chemistry
  • Benzamidines / pharmacology
  • Drug Design
  • Guinea Pigs
  • Histamine Antagonists / chemical synthesis*
  • Histamine Antagonists / chemistry
  • Histamine Antagonists / pharmacology
  • Imidazoles / chemical synthesis*
  • Imidazoles / chemistry
  • Imidazoles / pharmacology
  • In Vitro Techniques
  • Indicators and Reagents
  • Kinetics
  • Ligands
  • Molecular Conformation
  • Molecular Structure
  • Muscle Contraction / drug effects
  • Muscle Contraction / physiology
  • Muscle, Smooth / drug effects
  • Muscle, Smooth / physiology
  • Receptors, Histamine H3 / drug effects
  • Receptors, Histamine H3 / physiology*

Substances

  • Benzamidines
  • Histamine Antagonists
  • Imidazoles
  • Indicators and Reagents
  • Ligands
  • Receptors, Histamine H3